Bregni, M <br/><br/>
Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.  [electronic resource] 

 -  Cancer research  Mar 1986 
 - 1208-13 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Ammonium Chloride--pharmacology<br/>Antibodies, Monoclonal--administration & dosage<br/>Antigens, Neoplasm--immunology<br/>Bone Marrow Cells<br/>Bone Marrow Transplantation<br/>Burkitt Lymphoma--immunology<br/>Cell Line<br/>Cell Survival--drug effects<br/>Colony-Forming Units Assay<br/>Complement System Proteins--immunology<br/>Dose-Response Relationship, Drug<br/>Hematopoietic Stem Cells--cytology<br/>Histocompatibility Antigens Class II--immunology<br/>Humans<br/>Immunotherapy<br/>In Vitro Techniques<br/>Neoplastic Stem Cells--immunology<br/>Receptors, Antigen, B-Cell--immunology<br/>Ricin--administration & dosage